All information is correct at time of printing and is subject to change without notice. The Devon Formulary and Referral Website is not in any way liable for the accuracy of any information printed and stored by users. For the most up-to-date information, please refer to the website.
Formulary
Back
Contact us about this page
Chapter 1: Gastrointestinal
Toggle Parent Pages
Print this page
Irritable bowel syndrome guidance
Management of constipation in adults
Management of constipation in children
Management of diarrhoea in children
Management of dyspepsia and gastro-oesophageal reflux disease
Paediatric reflux disease guidance
Infantile colic guidance
1.1 Dyspepsia and gastro-oesophageal reflux disease
1.2 Antispasmodics and other drugs altering gut motility
1.3 Antisecretory drugs and mucosal protectants
1.4 Antimotility drugs
1.5 Chronic bowel disorders
1.6 Laxatives
1.7 Local preparations for anal and rectal disorders
1.8 Stoma care
1.9 Drugs affecting intestinal secretions
Page last updated:
5 October 2020
Contact us about this page
1.3.3 Chelates and complexes
First Line
Second Line
Specialist
Hospital Only
Sucralfate
- Oral suspension sugar free 1g/5ml (£224.35 = 200ml)
- Tablets 1g (unlicensed preparation)
Indications
- Prophylaxis of gastrointestinal haemorrhage from stress ulceration
- Biliary reflux (unlicensed indication)
- Oesophageal varices (unlicensed indication)
Dose
- Prophylaxis of gastrointestinal haemorrhage from stress ulceration:
- 1g six times daily; maximum 8g daily
Notes
- Sucralfate tablets are now unlicensed and are only available as a "special-order" at significantly increased cost, please exhaust all other formulary options before prescribing
- Sucralfate oral suspension sugar free is not licensed for use in children under 14 years
- Bezoar formation: Following reports of bezoar formation associated with sucralfate, caution is advised in seriously ill patients, especially those receiving concomitant enteral feeds or those with predisposing conditions such as delayed gastric emptying
